baber/WOPTO huggingface dataset:
Patent CA-2504643-A1 (CA)
Inventor: WU LINGYUN
IPC: A61P9/12
Filed: 2005-04-21
Abstract: The present invention relates to methods of treating conditions which benefit from an upregulation of the HO/CO pathway, said methods comprising the chronic administration of an effective amount hemin or a hence-containing compound to an subject in need thereof.
Patent CA-2504741-A1 (CA)
Inventor: YU TSUNG-I
IPC: A63F13/98
Filed: 2005-04-12
Abstract: Disclosed is a mobile battery-charging container, which includes a container body for accommodating a mobile electronic device, a spare battery, for example, a primary or secondary battery mounted inside the container body, and a circuit board, which is mounted inside the container body and electrically connected to the spare battery and which has a terminal connectable to the mobile electronic device accommodated in the container body and a charging circuit for charging the battery of the mobile electronic device accommodated in the container body with the battery power of the spare battery through the terminal.
Patent CA-2508465-A1 (CA)
Inventor: JACQUET ARNAUD
IPC: G06Q10/00
Filed: 2003-12-11
Abstract: La présente invention concerne le concept de canal de réseau qui est utilisé en tant que canal d'attente, selon lequel les membres d'un groupe autre qu'un premier membre rejoignent le canal d'attente tout en exécutant une action ou un processus, puis quittent le canal d'attente une fois que l'action ou le processus est exécuté. Une fois que tous les membres ont quitté le canal d'attente, le premier membre du groupe exécute alors une action ou un processus. Afin d'indiquer au premier membre que tous les autres membres ont quitté le canal d'attente, un protocole tel que le protocole MSNIP (Multicast Source Notification of Interest Protocol) peut être utilisé.
Patent CA-2509288-A1 (CA)
Title: Method for delivering drugs to the adventitia using device having microprojections
Inventor: KRULEVITCH PETER
IPC: A61F2/958
Filed: 2005-06-07
Abstract: A method for delivering a therapeutic agent into tissue includes providing a device for delivering a therapeutic agent into tissue. The device has an elongated body; a first balloon in the body expandable from a collapsed position to an expanded position; a second balloon in the body expandable from a collapsed position to an expanded position. The second balloon has a plurality of apertures therein; and a therapeutic agent is located in the second balloon. A plurality of microprojections are located on a surface of the second balloon for penetrating tissue. Upon expansion of the first balloon from the collapsed position to the expanded position, the second balloon is expanded from the collapsed position to the expanded position for deploying the plurality of microprojections into tissue and for dispensing the therapeutic agent from the second balloon into the tissue through the plurality of apertures. The device is placed adjacent a site in the tissue; and the therapeutic agent is delivered into the tissue at the site by expanding the first balloon from the collapsed position to the expanded position.
Patent CA-2509503-A1 (CA)
Inventor: MOGIL MELVIN S
IPC: A45C7/00
Filed: 2003-10-01
Abstract: A soft sided insulated container assembly includes a first portion having an insulated, soft sided external wall structure, and an internal, substantially rigid molded plastic receptacle mounted therein. It has a cover structure that includes a reinforcement member for engaging a land region of the molded receptacle, thereby tending to yield an interface tending to have a sealing relationship. The container may also include a thermal storage element, and the container may have an accommodation for receiving the thermal storage element.
Patent CA-2510864-A1 (CA)
Inventor: MILNER SCOTT T
IPC: C08F8/00
Filed: 2003-12-19
Abstract: L'invention concerne de nouveaux procédés de polymérisation comprenant des diluants contenant des hydrofluorocarbones, et leur utilisation dans la production de nouveaux polymères ne présentant sensiblement pas de ramifications à chaîne longue. L'invention concerne en particulier des copolymères d'une isooléfine, de préférence l'isobutylène, et d'une multioléfine, de préférence un diène conjugué, et plus préférablement l'isoprène, ne présentant sensiblement pas de ramifications à chaîne longue.
Patent CA-2511257-A1 (CA)
Inventor: YANG JINPING
IPC: A61K35/32
Filed: 2002-01-17
Abstract: L'invention concerne une méthode pour stimuler la croissance osseuse sur un site d'un patient nécessitant une ostéoinduction ou une réparation du cartilage. Cette méthode consiste à administrer sur ledit site une quantité thérapeutiquement efficace d'un agoniste du récepteur de la thrombine activé de manière non-protéolytique. La présente invention porte également sur une méthode pour stimuler la prolifération et l'expansion de chondrocytes in vitro, cette méthode consistant à cultiver des chondrocytes en présence d'une quantité stimulante d'un agoniste NPAR.
Patent CA-2513081-A1 (CA)
Inventor: SAWADA KOZO
IPC: A61P31/00
Filed: 2003-12-26
Abstract: La présente invention concerne un composé de la formule (1) ou un sel de ce dernier, dans laquelle R?1¿, R?2¿, R?3¿ et R?4¿ sont tels que définis dans la description, leur utilisation comme médicament, leur procédé de préparation et leur utilisation dans le traitement de maladies médiées par PDE-IV ou TNF-.alpha..
Patent CA-2514418-A1 (CA)
Inventor: DEVINE RICHARD C
IPC: E04D5/14
Filed: 2004-02-02
Abstract: A two-piece fastener plate and fastener assembly and method of securing a roof membrane to a roof deck wherein the fastener is reinforced with concentric dome-shaped ribs separated by concentric depressions or dimples. The concentric depressions or dimples are provided with pairs of barbs for gripping the roof membrane when the fastener secures the roof membrane to the roof deck.
Patent CA-2514854-A1 (CA)
Title: Milk component-based sweet comprising defined edible fat agglomerates, and method and device for the production thereof
Inventor: VENNERI SALVATORE
IPC: A23L9/20
Filed: 2004-02-12
Abstract: The invention relates to a sweet that has a long shelf life and is provided in the form of a soft, creamy, shape-retaining, and foamed mass comprising milk components, edible fats, sugar and/or sugar substitutes, and water. At least one portion of the edible fat is provided in a crystallized form at ambient temperature. The inventive sweet does not contain any lactose crystals that can be perceived by the consumer. The milk protein content amounts to 5.5 to 20 % by weight while the fat-free dry milk content ranges between 14 and 55 %  by weight and the degree of denaturation of the whey protein amounts to <= 10 %. The inventive sweet is characterized by the fact that the crystallized and non-crystallized edible fat agglomerates have a volume-related particle size D50,3 of 3.5 to 18 ~m.
Patent CA-2516576-A1 (CA)
Inventor: FLOYD PHILIP D
IPC: B81B7/02
Filed: 2005-08-22
Abstract: A method of sealing a microelectromechanical system (MEMS) device 76 from ambient conditions is described, wherein the MEMS device 76 is formed on a substrate 72 and a substantially hermetic seal 78 is formed as part of the MEMS device manufacturing process. The method comprises forming a metal seal 78 on the substrate proximate a perimeter of the MEMS device 76 using a method such as photolithography. The metal seal 78 is formed on the substrate while the MEMS device 76 retains a sacrificial layer between conductive members of MEMS elements, and the sacrificial layer is removed after formation of the seal and prior to attachment of a backplane 74.
Patent CA-2517001-A1 (CA)
Title: Hemorrhoid treatment pad
Inventor: OSBORN THOMAS WARD III
IPC: A61F13/15
Filed: 2004-02-20
Abstract: A hemorrhoid treatment pad, the hemorrhoid treatment pad having a substance on a body facing surface thereof, the substance comprising a skin care composition. The skin care composition can have from about 0.001% to about 0.1% by weight of hexamidine; from about 0.001% to about 10% by weight of zinc oxide; from about 0.01% to about 10% by weight of niacinamide; and a carrier.
Patent CA-2517937-A1 (CA)
Title: Hospital telephone and device controller
Inventor: HEIMBROCK RICHARD HENRY
IPC: H04M11/00
Filed: 2005-09-01
Abstract: A hand-held pendant operating as a telephone and a controller of one or more functions of a patient-support apparatus is disclosed. The hand-held pendant has a complementary holster which mounts in the siderail of the patient-support apparatus and serves to retain the hand-held pendant. The hand-held pendant has two sides, one functioning as a telephone and the other as a controller for one or more functions of a patient-support apparatus.
Patent CA-2518901-A1 (CA)
Inventor: PALMATEER LAUREN
IPC: B81B7/04
Filed: 2005-09-13
Abstract: Disclosed is an electronic device utilizing interferometric modulation and a package of the device. The packaged device includes a substrate 101, an interferometric modulation display array 111 formed on the substrate 101, and a back-plate 130. The back-plate is placed over the display array 111 with a gap 124 between the back-plate and the display array.  The depth of the gap may vary across the back-plate. The back-plate can be curved or have a recess on its interior surface facing the display array. Thickness of the back-plate may vary. The device may include reinforcing structures which are integrated with the back-plate.
Patent CA-2520830-A1 (CA)
Inventor: SOMA YOSHIAKI
IPC: C07K16/28
Filed: 2004-03-31
Abstract: It is intended to provide a method of inducing the differentiation and/or promoting the proliferation of regulatory T cells; a method of inhibiting vessel flow-mediated endothelial cell migration of immune cells;  immunosuppression methods using these methods; and a medicinal composition to be used in these methods. Namely, a method of inducing the differentiation and/or promoting the proliferation of regulatory T cells by treating CD52-expressing T cells with a CD52 agonist containing anti-CD52 antibody, a method of inhibiting vessel flow-mediated endothelial cell migration of immune cells, and immunosuppression methods using these methods.
Patent CA-2521932-A1 (CA)
Inventor: WELLER THOMAS
IPC: C07D211/78
Filed: 2004-04-26
Abstract: The invention relates to novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
Patent CA-2526909-A1 (CA)
Inventor: DEMOLE FREDERIC JEAN-PIERRE
IPC: G09F11/00
Filed: 2004-05-10
Abstract: A system for displaying alphanumeric characters in airports, train stations or cinemas. The system comprises a small robot (1) on a rail (2) that can move along a stack of cards (3) on which alphanumerical characters are printed. The robot (1) is able to pick-up any card, place it on a mobile holding means (4).  By repeating this operation words, numbers or codes can be formed. The holding means (4) is mobile in order to be in such a position as to exchange cards or in a position to display the composed information. The system provides for simplified pick-up, placing and retrieving operation and does not expose the hardware of the system to the public.
Patent CA-2528097-A1 (CA)
Inventor: HALL DAVID B
IPC: G01D5/353
Filed: 2004-06-18
Abstract: A sensor array employs a parameter to induce a time-varying phase angle .phi.  on an optical signal that comprises a phase generated carrier with a demodulation phase offset .beta.. The phase angle .phi. is calculated independently of the demodulation phase offset .beta..
Patent CA-2528172-A1 (CA)
Title: Native analyte as reference in lateral flow assays
Inventor: LEDDEN DAVID J
IPC: G01N33/558
Filed: 2004-06-03
Abstract: This invention is directed to a lateral flow assay for detecting the presence of an analyte in a liquid test sample. The lateral flow assay represents an improvement in the ability to accurately and with high fidelity to detect the presence or absence of a target analyte in a liquid sample, in part, by encompassing a reference region of immobilized, non-diffusible analyte that allows for detection of any factors that interfere with the interaction and binding of the analyte to the labeled capture reagent. Any influences on the interaction and binding of the analyte that is free in solution in the liqiuid test sample to its complementary labeled reagent will be encountered in parallel in the binding between the immobilized analyte in reference region to the labeled reagent as it diffuses through the reference region. In one embodiment, the lateral flow assay of the invention is a urine-based human Chorionic Gonadotropin (hCG) assay.
Patent CA-2528498-A1 (CA)
Title: Frame work for storing, retrieving and displaying real-time data
Inventor: AMIRTHALINGAM RAJA
IPC: G05B23/02
Filed: 2004-05-27
Abstract: A frame work for storing, retrieving and displaying real-time data. The framework includes software known as tools for data acquisition, that is, logging, file conversion and data analysis/display. Scalar and array type data are simultaneously handled during data logging and further processing. The data-logging tool creates short-term data in a binary file format and the file conversion software acquires long term data from the short-term data. Process condition based conversion and periodic conversion are also included in the architecture. Each of the three components of the framework allows for user selection of parameters to maximize the benefit of the tools. The data display component offers automatic or user input based switching between the live data (online) and history data (offline) modes according to computational intensity.
Patent CA-2529638-A1 (CA)
Title: Cantilever shelving for utility shed
Inventor: RICHARDSON JED C
IPC: A47B96/02
Filed: 2005-12-09
Abstract: A cantilevered shelving system is provided for manual assembly along the wall panels of a molded utility shed.      Several shelves are provided that are removably secured to brackets that removably fasten into reinforcing strips in the wall panels. Each shelf is supported by at least two triangular brackets near the opposite ends. The brackets have upper and lower fasteners on a vertical leg that pivotably connect to the shed through apertures in the reinforcing strips.
Patent CA-2531083-A1 (CA)
Inventor: LEHTIMAKI TARJA
IPC: A61P25/14
Filed: 2004-07-02
Abstract: The present invention relates to a method for the treatment of sensorimotor dysfunctions caused by brain trauma with an inhibitor of prolyl oligopeptidase or a pharmaceutically acceptable ester or salt thereof.
Patent CA-2531861-A1 (CA)
Title: Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
Inventor: RABE HOLGER
IPC: A61K31/4164
Filed: 2004-06-28
Abstract: The present invention relates to the use of 1-ar(alk)ylimidazolin-2-ones which contain a disubstituted amine radical in the 4-position for the treatment or prevention of central nervous system disorders including depression, anxiety, movement disorders, and especially dystonia, and psychotic disorders, and especially schizophrenia and psychotic symptoms associated to other mental disorders.
Patent CA-2533727-A1 (CA)
Title: Vehicle seat assembly and floor rail for lateral seat shuttling
Inventor: PATHAK SHRIRAM SHIVANAND
IPC: B60N2/30
Filed: 2004-08-02
Abstract: A riser assembly for selectively coupling a seat assembly to a front slide rail and rear slide rail on the floor of an automotive vehicle. The riser assembly includes a front latch mechanism adapted to be operatively coupled to the front slide rail. The front latch machanism has a support plate for supporting the riser assembly on the front slide rail. A rear latch machanism is adapted to be operatively coupled to the rear slide rail. The rear latch mechanism has a mounting plate for supporting the riser assembly on the rear slide rail and a pair of opposing front and rear latch plates for selectively engaging and securing the rear latch mechanism to the rear slide rail. A  release cam member is operatively coupled between the front and rear latch plates for simultaneously engaging and releasing the front and rear latch plates from engagement with the rear slide rail to selectively couple the riser assembly to the front and rear slide rails.
Patent CA-2534210-A1 (CA)
Inventor: BLUMENFELD MICHAEL
IPC: C01B32/50
Filed: 2004-07-24
Abstract: The invention relates to a method for extracting hydrogen from a gas containing methane, especially natural gas. Hydrocarbons contained in the gas are catalytically broken down in a reformer (4) by steam in order to form hydrogen, carbon monoxide and carbon dioxide. Catalytic conversion of the obtained carbon monoxide with steam occurs in a downstream conversion step in order to form carbon monoxide and water. Carbon dioxide is removed from the converted gas flow (8) by gas washing (7), and the washed hydrogen-rich gas flow (10) is subsequently divided in a pressure-swing adsorption system (11) into a product gas flow (12) made of hydrogen and a waste gas flow (13). The waste gas flow (13) is introduced with hydrogen (14), which is separated from the gas flow (10) after gas washing, into a reformer (4) which is essentially a carbon-free combustible gas, and is combusted there. The invention also relates to a system for carrying out said method.
Patent CA-2534695-A1 (CA)
Title: Method for encoding moving image and method for decoding moving image
Inventor: ABE KIYOFUMI
IPC: H04N7/26
Filed: 2004-07-28
Abstract: When a deblocking filter applied to the luminance component is used with reference to the color difference component, the pixel position of a target color difference component is referred to after being converted (F7a) to mat ch the pixel position of a luminance component belonging to the same field. Whe n it is displayed while being interlaced, the luminance component and the colo r difference component are filtered with an identical intensity and a more natural image can be created.
Patent CA-2534828-A1 (CA)
Title: Novel cxcl8 antagonists
Inventor: SHAW JEFFREY
IPC: C12N15/24
Filed: 2004-10-22
Abstract: Novel antagonists of the chemokine CXCL8 (also known as Interleukin-8) can be obtained by generating mutants having specific combinations of non-.conservative substitutions of basic amino acids located in the C-terminal region. Compounds prepared in accordance with the present invention can be used to block CXCL8 activity in vivo, thereby providing therapeutic compositions for use in the treatment or prevention of CXCL-8-related diseases.
Patent CA-2535167-A1 (CA)
Inventor: SCHAEFER THOMAS
IPC: B60K15/03
Filed: 2001-12-12
Abstract: A fuel tank for a motor vehicle and a vent unit for the fuel tank incorporate interchangeable components to facilitate and reduce the costs of repair and maintenance. This is achieved by an arrangement of components in which the fuel tank comprises at least one fuel filling opening, at least one fuel delivery pump, at least one operational vent means and at least one refueling vent valve. The vent means and vent valve are connected to a fuel vapor filter by way of at least one vent conduit. At least one bead removal container is connected on the upstream side of the fuel vapor filter. At least the bead removal container and the refueling vent valve are combined to form a functional unit in the form of a vent unit adapted to fit into an opening through the wall of the tank.
Patent CA-2542514-A1 (CA)
Inventor: LENNON PATRICK J
IPC: C07D239/42
Filed: 2004-10-11
Abstract: Compounds of Formula (I): wherein A, X, R2 and R4 are as defined herein, are disclosed.
Patent CA-2542560-A1 (CA)
Title: Method for producing scyllo-inositol
Inventor: KITA YUICHI
IPC: C12N9/04
Filed: 2004-10-14
Abstract: It is intended to provide a novel NAD+-independent myo-inositol 2-dehydrogenase which converts myo-inositol into scyllo-inosose in the absence of NAD+; a novel enzyme scyllo-inositol dehydrogenase which stereospecifically reduces scyllo-inosose into scyllo-inositol in the presence of NADH or NADPH;  and a novel microorganism which belongs to the genus Acetobacteror Burkholderia and can convert myo-inositol into scyllo-inositol. By using these enzymes or the microorganism, scyllo-inositol is produced. Further, scyllo-inositol is purified by adding boric acid and a metal salt to a liquid mixture containing scyllo-inositol and a neutral saccharide other than scyllo-inositol to form a scyllo-inositol/boric acid complex, separating the complex from the liquid mixture, dissolving the thus separated complex in an acid to give an acidic solution or an acidic suspension and then purifying scyllo-inositol from the acidic solution or the acidic suspension.
Patent CA-2544273-A1 (CA)
Title: Distributed delegated path discovery and validation
Inventor: ENGBERG DAVID
IPC: G06F11/30
Filed: 2004-11-19
Abstract: Providing path validation information for a system includes determining paths between a subset of certificate of the system and at least one trust root, storing each of the paths in a table prior to a request for path validation information, and fetching the validation information stored in the table in response to a request for path validation information. Providing path validation information may also include digitally signing the validation information. Providing path validation information may also include applying constraints to the validation information and only providing validation information that is consistent with the constraints. Determining paths may include constructing a directed graph of trusted roots and the subset of certificates and performing a depth-first acyclic search of the graph.
Patent CA-2545932-A1 (CA)
Title: Intra-cavity catheters and methods of use
Inventor: EVANS STEPHEN
IPC: A61F2/958
Filed: 2004-11-12
Abstract: Catheters for performing therapeutic and diagnostic procedures within a body, including human or animal body cavities or lumens, and methods for use. One or more distancing member of the catheter can be used to position a sensor or a therapeutic device a minimum distance from a wall of a lumen or cavity. The catheter can include means for actively or passively controlling or modulating its position within the lumen or cavity during a procedure. Methods for using the catheter include nonocclusive deployment in the human gastrointestinal tract for phototherapy procedures, delivering electromagnetic radiation substantially homogeneously or in a desired pattern to the interior of a lumen.
Patent CA-2547581-A1 (CA)
Title: Method of activating the shrink characteristic of a film
Inventor: HAVENS MARVIN R
IPC: B29C71/04
Filed: 2006-05-23
Abstract: A method of activating the shrink characteristic of a film comprises two steps. First, a film comprising one or more thermoplastic polymers and at least about 0.01 weight % photothermic material is provided. Second, the film is exposed to an amount of non-ionizing radiation effective for the photothermic material to generate heat to cause an effect selected from one or more of: 1) shrinking the film by at least about 5% in at least one direction, and 2) increasing the tension in the film by at least about 50 pounds per square inch in at least one direction.